Lab Canada

Product News

Electroporation system for vaccine development and gene therapy


The AgilePulse In Vivo electroporation system features variable pulse amplitude technology for vaccine delivery or gene therapy applications. These waveforms consist of multiple, low to high voltage pulses with variable pulse lengths, which promotes greater cell membrane poration; resulting in maximum transfection efficiency with minimal damage to the cells or tissues. Suitable for vaccine development, intra-dermal gene delivery, intra-muscular gene delivery, intra-tumor gene delivery, this machine also has resistance measurement for proper needle placement and reproducibility and a specially designed needle arrays for intra-muscular or intra-dermal applications

BTX


Print this page

Related